Dr Schwarz has published more then 150 scientific articles in international peer reviewed journals, several book chapters and books in Cardiology and Sexual Medicine.



  1. Massarrat S, Schumann KM, Schwarz ER. Variation of total pepsin activity in sera with age and under different stimulations of gastric acid secretion. Clin Biochem 22:99-101; 1989.


  1. Sack S, Mohri M, Arras M, Schwarz ER, Schaper W. Ischaemic preconditioning - time course of renewal in the pig. Cardiovasc Res 27: 551-555; 1993.


  1. Sack S, Mohri M, Schwarz ER, Arras M, Schaper J, Ballagi-Pordany G, Scholz W, Lang HJ, Schölkens BA, Schaper W. Effects of a new Na+/H+ antiporter inhibitor on postischemic reperfusion in pig heart. J Cardiovasc Pharmacol 23:72-78; 1994.


  1. Tebbe U, Windeler J, Boesl I, Hoffmann H, Wojcik J, Ashmawy M, Schwarz ER, Loewis of Menar P, Rosemeyer P, Hopkins G, Barth H on behalf of the LIMITS Study group. Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS Study). J Am Coll Cardiol 26:365-73; 1995.


  1. Schwarz ER, Schaper J, vom Dahl J, Altehoefer C, Grohmann B, Schoendube F, Sheehan FH, Uebis R, Buell U, Messmer BJ, Schaper W, Hanrath P. Myocyte degeneration and cell death in hibernating human myocardium. J Am Coll Cardiol 27:1577-1585; 1996.
  1. Schwarz ER, Klues HG, vom Dahl J, Klein I, Krebs W, Hanrath P. Functional, angiographic and intracoronary Doppler flow characteristics in symptomatic patients with myocardial bridging: effect of short-term intravenous beta-blocker medication. J Am Coll Cardiol 27:1637-1645; 1996.
  1. vom Dahl J, Altehoefer C, Buechin P, Sheehan FH, Schwarz ER, Koch KC, Schulz G, Uebis R, Schoendube F, Messmer BJ, Buell U, Hanrath P. Einfluß von Myokardvitalität und Koronarrevaskularisation auf klinische Entwicklung und Prognose: Eine Verlaufsbeobachtung bei 161 Patienten mit koronarer Herzkrankheit. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: An observational study in 161 patients with coronary artery disease] Z Kardiol 85: 868-881; 1996.


  1. Schwarz ER, Klues HG, vom Dahl J, Klein I, Krebs W, Hanrath P. Functional characteristics of myocardial bridging. A combined angiographic and intracoronary Doppler flow study. Europ Heart J 18:434-442; 1997.
  1. Schwarz ER, Buettgen S, vom Dahl J, Maurin N, Fuezesi L, Sieberth HG, Hanrath P. A case of Ehlers-Danlos syndrome type IV with dilated coronary sclerosis and myocardial infarction in a young man. J Invas Cardiol 9: 274-277; 1997.
  1. Schwarz ER, Przyklenk K, vom Dahl J, Schoendube F, Hanrath P, Kloner RA. Chronic hibernating myocardium: concepts and controversies. Cong Heart Fail 3:12-23; 1997.
  1. vom Dahl J, Altehoefer C, Sheehan FH, Buechin P, Schulz G, Schwarz ER, Koch KC, Uebis R, Messmer BJ, Buell U, Hanrath P. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18--FDG PET on clinical outcome in coronary artery disease. J Nucl Med 38:742-748; 1997.
  1. Schwarz ER, Montino H, Fleischhauer J, Klues HG, vom Dahl J, Hanrath P. The angiotensin II receptor antagonist EXP 3174 reduces infarct size comparable to enalaprilat and augments preconditioning in the pig heart. Cardiovasc Drugs Ther 11:687-695; 1997.
  1. Schwarz ER, Patterson M, Kloner RA. Kardiomyozytentransplantation - eine “Frischzellenkur“ zur Gewebsreparatur in infarzierten Herzen? [Myocyte engraftment to replace jeopardized and dead myocardial tissue - fad or future?] Z Kardiol 87:1-7; 1997.
  1. Schwarz ER, Whyte WS, Kloner RA. Ischemic preconditioning. Curr Op Cardiol 12:475-481; 1997.
  1. Klues HG, Schwarz ER, vom Dahl J, Reffelmann T, Reul H, Potthast K, Schmitz C, Minartz J, Krebs W, Hanrath P. Disturbed intracoronary hemodynamics in myocardial bridging - early normalization by intracoronary stent placement. Circulation 96:2905-2913; 1997.
  1. Kloner RA, Schwarz ER, Prejean C, Kay G. Resupplying the infarcted myocardium with myocytes. Editorial comment. Circulation 96 (Suppl. II)II-186-II-187; 1997.


  1. Schwarz ER, Fleischhauer J, Montino H, Chakupurakal R, Foresti M, Schuetz T, Sack S, Mohri M, Arras M, Schaper W, Hanrath P. Infarct size reduction by ischemic preconditioning is a monophasic, short-lived phenomenon in anesthetized pigs. J Cardiovasc Pharmacol Therapeut 3:63-70; 1998.
  1. Schwarz ER, Schoendube FA, Kostin S, Schmiedtke N, Schulz G, Buell U, Messmer BJ, Morrison J, Hanrath P, vom Dahl J. Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function following revascularization. J Am Coll Cardiol 31:1018-1026; 1998.
  1. Schwarz ER, Pollick C, Dow J, Patterson M, Birnbaum Y, Kloner RA. A small animal model of non-ischemic cardiomyopathy and its evaluation by transthoracic echocardiography. Cardiovas Res 39:216-223; 1998.
  1. Speakman MT, Schwarz ER, Kloner RA. Stress and the heart. Medicine & Behavior 4:42-45; 1998.
  1. Schwarz ER, Speakman MT, Kloner RA. The impact of heart disease on sexual function. Medicine & Behavior 8:35-38; 1998.
  1. Schwarz ER, Hager PK, Uebis R, Hanrath P, Klues HG. Myocardial ischaemia in a case of a solitary coronary ostium in the right aortic sinus with retroaortic course of the left coronary artery - documentation of the underlying pathophysiologic mechanisms of ischemia by intracoronary Doppler and pressure measurements. Heart 80:307-311; 1998.
  1. Schwarz ER, Pollick C, Meehan WP, Kloner RA. Evaluation of cardiac structures and function in small experimental animals: transthoracic, transesophageal, and intraventricular echocardiography to assess contractile function in rat heart. Bas Res Cardiol 93:477-486; 1998.
  1. Schulz G, vom Dahl J, Kaiser HJ, Banneitz L, Herzog H, Schwarz ER, Hamacher K, Buell U. Myocardial uptake and kinetics of 14(R,S)-(18-F)-fluoro-6-thiaheptadecanoic-acid (FTHA) in patients with advanced coronary heart disease. Nuklearmedizin 37:49-53; 1998.


  1. Schwarz ER, Reffelmann Th, Kloner RA. Clinical effects of ischemic preconditioning. Curr Opin Cardiol 14:340-348; 1999.
  1. Schwarz ER, Reffelmann Th, Schoendube F, Herrmanns B, Chakupurakal R, Doerge H, Schuetz Th, Foresti M, Messmer BJ, Radke PW, vom Dahl J, Hanrath P. Hypoxic hypoperfusion fails to induce myocardial hibernation in anesthetized swine. J Cardiovasc Pharmacol Therapeut 4:235-247; 1999.
  1. Schwarz ER, Speakman MT, vom Dahl J, Kloner RA. Hibernating myocardium – is there evidence for chronic flow reduction? Heart Disease 1:155-162; 1999.
  1. Radke PW, Janssens U, Schwarz ER, vom Dahl J. Therapeutic dissolution of an intracoronary thrombus by prolonged intravenous platelet glycoprotein IIb/IIIa antagonism. J Invas Cardiol 11:679-681; 1999.


  1. Schwarz ER, Speakman MT, Kloner RA. A new model of ventricular plication: a suturing technique to decrease left ventricular dimensions, improve contractility, and attenuate ventricular remodeling after myocardial infarction in the rat heart. J Cardiovasc Pharmacol Therapeut 5:41-49; 2000.
  1. Schwarz ER, Speakman MT, Patterson M, Hale SH, Kedes LK, Isner JM, Kloner RA. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor in a myocardial infarction model in the rat - angiogenesis and angioma formation. J Am Coll Cardiol 35:1323-1330; 2000.
  1. Reffelmann T, Schwarz ER, Skobel CE, Petek O, Hanrath P. (Ischemic preconditioning. Does this animal model have clinical relevance?) Med Klin 95:559-567; 2000.
  1. Makropoulos W, Kocher K, Heintz B, Schwarz ER, Mertens PR, Stefanidis L. Urinary thymidine glycol as a biomarker for oxidative stress after kidney transplantation. Renal Failure 22:499-510; 2000.
  1. Schwarz ER, Somoano Y, Hale S, Kloner RA. What is the required reperfusion period for assessment of myocardial infarct size using triphenyltetrazolium chloride staining in the rat? J Thrombosis & Thrombolysis 10:181-187; 2000.
  1. Schwarz ER, Heintz B, Stefanidis I, vom Dahl J, Sieberth HG. The inhomogeneous and delayed course of blood pressure normalization in hypertensive patients after bilateral nephrectomy with and without subsequent renal transplantation. Renal Failure 22:591-60; 2000.
  1. Haager PK, Schwarz ER, vom Dahl J, Klues HG, Reffelmann T, Hanrath P. Long term angiographic and clinical follow-up in patients following stent implantation for symptomatic myocardial bridging. Heart 84:403-408; 2000.
  1. Skobel E, Kaminski R, Breuer C, Reffelmann T, Schwarz ER. Sistieren nächtlicher pathologischer Atmungsmuster nach orthotoper Herztransplantation. [Remission of noctural pathologic respiratory patterns after orthotopic heart transplantation. A case report and overview of current status of therapy]. Med Klinik 95:706-711; 2000.
  1. Schwarz ER, Patterson M, Kloner RA. Transplantation of fetal left ventricles in myocardial infarct tissue: a new pouch technique, its detection, survival, and impact on cardiac function in the rat heart. J Card Vasc Regen 1:97-105; 2000.
  1. Nowak B, Zimny M, Schwarz ER, Kaiser HJ, Schäfer W, Reinartz P, vom Dahl J, Buell U. Diagnosis of myocardial viability by dual-head coincidence gamma camera 18-F-fluorodeoxyglucose positron emission tomography with and without non-uniform attenuation correction. Europ J Nuclear Med 27:1501-1508; 2000.


  1. Krüger S, Piroth W, Takyi BA, Breuer C, Schwarz ER. Multiple aseptic pulmonary nodules with central necrosis in association with pyoderma gangrenosum. Chest 119:977-978; 2001.
  1. Herrmanns B, Brunn A, Schwarz ER, Sachweh J, Seipelt I, Schroeder JM, Vogel U, Schoendube FA, Buettner R. Fulminant toxoplasmosis in a heart transplant recipient. Pathology 1997:211-215; 2001.
  1. Hoffmann R, Haager P, Mintz GS, Kerckhoff G, Schwarz ER, Franke A, vom Dahl J, Hanrath P. The impact of high pressure vs low pressure stent implantation on intimal hyperplasia and follow-up lumen dimensions. Eur Heart J 22:2015-2024; 2001.
  1. Radke PW, Schwarz ER, Groesdonk H, Graf J, Janssens U. Thrombosis in Behcet’s disease: report of a case followed by a systematic review using the methodology of evidence-based medicine. J Thromb Thrombolysis 11:137-141; 2001.
  1. Reffelmann T, Skobel EC, Kammermeier H, Hanrath P, Schwarz ER. Activation of ATP-sensitive potassium channels in hypoxic cardiac failure is not mediated by adenosine-1 receptors in the isolated rat heart. J Cardiovasc Pharmacol Ther 6:189-200; 2001.


  1. Reffelmann T, Klues HG, Hanrath P. Schwarz ER. Post-stenotic coronary blood flow at rest is not altered by therapeutic doses of the oral antidiabetic drug clibenclamide in patients with coronary artery disease. Heart 87:54-60; 2002
  1. Lepper W, Sieswerda GT, Franke A, Heussen N, Kamp O, de Cock CC, Schwarz ER, Voci P, Visser CA, Hanrath P, Hoffmann R. Repeated assessment of coronary flow velocity pattern in patients with first acute myocardial infarction. J Am Coll Cardiol 39:1283-1289; 2002

Since employed by UTMB


  1. Schwarz ER. The safety of sexual activity and sildenafil in cardiac patients. Saudi Heart J 15:103-106; 2003
  1. Schwarz ER, Kersting PH, Reffelmann T, Meven DA, Al-Dashti R, Skobel EC, Klosterhalfen B, Hanrath P. Cardioprotection by carvedilol: anti-apoptosis is independent on beta-adrenoceptor blockage in the rat heart. J Cardiovasc Pharmacol Ther 8:207-15; 2003
  1. Fox KM et al. for the CAESAR Investigators. Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina, Eur Heart J 24:2216-2212; 2003.


  1. Skobel EX, Schuh AXSchwarz ERX, Lin EA, Franke A, Breuer S, Günther K, Reffelmann T, Hanrath P, Weber C. Transplantation of fetal cardiomyocytes into infarcted rat hearts results in long-term functional improvement. Tissue Engineering 10:849-864; 2004. Xcontributed equally to the paper
  1. Reffelmann T, Sensebat O, Stroemer E, Birnbaum Y, Uretsky BF, Hanrath P, Schwarz ER. A novel minimal invasive model of myocardial infarction in swine. Cor Art Dis 15:7-12; 2004.
  1. Underwood SR, Bax JJ, vom Dahl J, Heinein MY, van Rossum A, Schwarz ER, Vanoverschelde JL, van der Wall EE, Wijns W. Imaging techniques for the assessment of myocardial hibernation. Europ Heart J 25:815-836; 2004.
  1. Angermann CE, Stoerk S, Costard-Jaeckle A, Dengler TJ, Tenderich G, Rahmel A, Schwarz ER, Naegele H, Wagner FM, Haaf B, Pethig K. Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients – the IMPROVED multicenter study. Europ Heart J 25:1626-1634; 2004.
  1. Birnbaum Y, Ye Y, Rosanio S, Tavackoli S, Yu ZY, Schwarz ER, Uretsky BF. Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury. Cardiovasc Res 65:345-355; 2005.
  1. Schwarz ER, Meven DA, Sulemanjee NZ, Kersting PH, Tussing T, Skobel EC, Hanrath P, Uretsky BF. MCP-1 induced monocyte infiltration produces angiogenesis but not arteriogenesis in chronically infarcted myocardium. J Cardiovasc Pharmacol Therapeut 9:279-289; 2004.


  1. Schuh A, Breuer S, Al Dashti R, Sulemanjee N, Hanrath P, Weber C, Uretsky BF, Schwarz ER. Administration of VEGF adjunctive to fetal cardiomyocyte transplantation and improvement of cardiac function in the rat model. J Cardiovasc Pharmacol Therapeut 10:55-66, 2005.
  1. Sanghi P, Uretsky BF, Schwarz ER. Vasopressin antagonism - a future treatment option in heart failure. Europ Heart J 26:538-543; 2005.
  1. Skobel E, Dannemann O, Reffelmann T, Boehm V, Weber C, Hanrath P, Uretsky BF, Schwarz ER. Carvedilol protects myocardial cytoskeleton during hypoxia in the rat heart. J Appl Res 5:378-386, 2005.
  1. Gupta R, Rahman MA, Uretsky BF, Schwarz ER. Left main coronary artery thrombus: a case series with different outcomes. J Thrombosis & Thrombolysis 19:125-131, 2005
  1. Schwarz ER, Gupta R, Diep TP, Nowak B, Kostin S, Grohmann B, Uretsky BF, Schaper J. Carvedilol improves myocardial contractility compared with metoprolol in patients with chronic hibernating myocardium after revascularization. J Cardiovasc Pharmacol Ther 10:181-190, 2005.
  1. Rosanio S, Schwarz ER, Ahmad M, Jammula P, Vitarelli A, Uretsky BF, Birnbaum Y, Ware DL, Atar S, Saeed M. Benefits, unresolved questions, and technical issues of cardiac resynchronization therapy for heart failure.Am J Cardiol 96:710-717, 2005.
  1. Schwarz ER. Sexual dysfunction and its relation to heart disease. Int J Impot Res 17 Suppl 1:S1-3, 2005.
  1. Schwarz ER, Rodriguez JJ. Sex and the heart. Int J Impot Res 17, Suppl 1:S4-6, 2005.
  1. Schwarz ER, Rastogi S, Rodriguez JJ, Kapur V, Sulemanjee N, Gupta R, Rosanio S. A multidisciplinary approach to assess erectile dysfunction in high-risk cardiovascular patients. Int J Impot Res 17 Suppl 1:S37-43, 2005.
  1. Rastogi S, Rodriguez JJ, Kapur V, Schwarz ER. Why do patients with heart failure suffer from erectile dysfunction? A critical review and suggestions on how to approach this problem. Int J Impot Res 17 Suppl 1:S25-36, 2005.
  1. Rodriguez JJ, Al Dashti R, Schwarz ER. Linking erectile dysfunction and coronary artery disease. Int J Impot Res 17 Suppl 1:S12-18, 2005.


  1. Schwarz ER, Sanghi P. Conivaptan – a selective vasopressin antagonist for the treatment of heart failure. Expert Review of Cardiovascular Therapy 4:17-23, 2006.
  1. Gupta R, Atar S, Schwarz ER, Uretsky BF, Birnbaum Y. Vineberg procedure for inadvertent injury to anomalous left anterior descending artery during tetralogy of fallot repair: four decades later. Tex Heart Inst J 33:98-99, 2006.
  1. Schwarz ER, Kapur V, Rodriguez JJ, Rastogi S, Rosanio S. The effects of chronic phosphodiesterase 5 inhibitor use on different organ systems. Int J Impot Res 2006 June 8 (Epub).
  1. Daher IN, Saeed M, Schwarz ER, Agoston I, Rahman MA, Ahmad M. Live three-dimensional echocardiography in diagnosis of interventricular septal perforation by pacemaker lead. Echocardiography 23:428-429, 2006.
  1. Saeed M, Rahman A, Afzal A, Agoston I, Jammula P, Birnbaum Y, Ware DL, Uretsky BF, Schwarz ER, Rosanio S. Role of transesophageal echocardiography guided cardioversion in patients with atrial fribrillation, previous left atrial thrombus and effective anticoagulation. Int J Cardiol 113:401-405, 2006.
  1. Kunapuli S, Rosanio S, Schwarz ER. How do cardiomyocytes die? Apoptosis and autophagic cell death in cardiac myocytes. J Cardiac Failure 12:381-391, 2006.
  1. Sulemanjee N, Schwarz ER. Conivaptan:monograph of a selective vasopressin antagonist. Drugs of Today 2006 (in press)
  1. Zarraga IG, Schwarz ER. Impact of Dietary Patterns and Interventions on Cardiovascular Health. Circulation 114:961-973, 2006. Erratum in Circulation 114:e577, 2006.
  1. Schwarz ER, Rastogi S, Kapur V, Sulemanjee N, Rodriguez JJ. Erectile dysfunction in heart failure patients. J Am Coll Cardiol 48:1111-1119, 2006.
  1. Schwarz ER, Jammula P, Gupta R, Rosanio S. A case and review of acromegaly-induced cardiomyopathy and the relationship between growth hormone and heart failure: cause or cure or neither or both? J Cardiovasc Pharmacology Ther 11:232-244, 2006.


  1. Rosanio S, Schwarz ER, Vitarelli A, Zarraga IG, Kunapuli S, Ware DL, Birnbaum Y, Tuero E, Uretsky BF. Sudden death prophylaxis in heart failure. Int J Cardiol 119:291-296, 2007.
  1. Zarraga IG, Schwarz ER. Coxibs and heart disease: what we have learned and what else we need to know. J Am Coll Cardiol 49:1-14, 2007.
  1. Schwarz ER. Sexual function in women with heart disease and coronary artery disease. Editorial. Int J Impot Res 19:341-342, 2007.
  1. Chien CV, Schwarz ER. Diabetes and sexual dysfunction. Diabetes 2007 (in press).
  1. 79. Rosanio S, Schwarz ER et al.. Late Right Ventricular Perforation and Hemothorax after Transvenous Defibrillator Lead Implantation. Texas Heart Institute J 2007 (in press).
  1. Chien C, Schwarz ER. Erectile dysfunction: risk factor or manifestation of cardiovascular disease. Int J Impot Res 19:446-447, 2007.
  1. Schwarz ER, Najam S, Akel R, Sulemanjee N, Bionat S, Rosanio S. Intermittent outpatient nesirtide infusion reduces hospital admissions in patients with advanced heart failure. J Cardiovasc Pharmacol Ther 12:232-236, 2007.
  1. Chien CV, Hackner D, Schwarz ER. Heart failure in very elderly population – a profile of heart failure in patients over the age of eighty. J Geriatric Cardiol 4,:20-24, 2007.
  1. Schwarz ER. Heart failure in the elderly – some aspects in pathophysiology, diagnosis, and therapy that require special attention. J Geriatr Cardiol 12:44-49, 2007.
  1. Schwarz ER, Kapur V, Bionat S, Rastogi S, Gupta R, Rosanio S. The prevalence and clinical relevance of sexual dysfunction in women and men with chronic heart failure. Int J Impot Res 20;Sept 20 (Epub), 2007.
  1. Kapur V, Schwarz ER. Relationship between erectile dysfunction and cardiovascular disease (Part 1). Rev Cardiovasc Med 2007l;8:214-9.


  1. Kapur V, Chien CV, Fuess JE, Schwarz ERThe relationship between erectile dysfunction and cardiovascular disease. Part II: The role of PDE-5 inhibition in sexual dysfunction and cardiovascular disease. Rev Cardiovasc Med 2008;9:187-95.
  1. Sulemanjee N, Merla A, Lick S, Aunon S, Taylor M, Manson M, Czer L, Schwarz ER. The First Year Post Heart Transplantation: Use of Immunosuppressive Drugs and Early Complications. J Cardiovasc Pharmacol Ther 2008 2008;13:13-31.
  1. Schwarz ER, Tehrani F. Sex and the Heart: More to Know About Sexual Dysfunction in Patients with Heart Failure. Southern Medical Journal 2008.
  1. Wertman BM, Gura V, Schwarz ERUltrafiltration for the management of acute decompensated heart failure. J Card Fail 2008;14:754-9.
  1. Goland S, Czer LS, Coleman B, De Robertis MA, Mirocha J, Zivari K, Schwarz ER, Kass RM, Trento A. Induction therapy with thymoglobulin after heart transplantation: impact of therapy duration on lymphocyte depletion and recovery, rejection, and cytomegalovirus infection rates. J Heart Lung Transplant 2008;27:1115-21.
  1. Uretsky BF, Birnbaum Y, Osman A, Gupta R, Paniagua O, Chamoun A, Pohwani A, Lui C, Lev E, McGehee T, Kumar D, Akhtar A, Anzuini A, Schwarz ER, Wang FW. Distal myocardial protection with intracoronary beta blocker when added to a Gp IIb/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome. Catheter Cardiovasc Interv 2008;72:488-97.
  1. Schwarz ER, Shen BJ. Sexual dysfunction in cardiac rehabilitation patients is much more than simply an epiphenomenon and needs more study. Rev Esp Cardiol. 2008;61:907-10.
  1. Simsir SA, Fontana GP, Czer LS, Schwarz ERHeart allograft transplanted twice. Eur J Cardiothorac Surg 2008;34:918-9.
  1. Wertman BM, Gura V, Schwarz ERUltrafiltration for the management of acute decompensated heart failure. J Card Fail 2008 ;14:754-9.


  1. Schwarz ER. Gupta R, vom Dahl J, Minartz J, Klues HG, Uretsky BF. Myocardial bridging in absence of coronary artery disease: proposal of a new classification based on clinical-angiographic data and long-term follow-up. Cardiology. 2009;112:13-21.
  1. Tehrani F, Phan A, Chien CV, Morrissey RP, Rafique AM, Schwarz ERValue of medical therapy in patients >80 years of age with heart failure and preserved ejection fraction. Am J Cardiol 2009;103:829-33. Erratum in: Am J Cardiol 2009;104:744.
  1. Dhesi P, Tehrani F, Fuess J, Schwarz ERHow does the heart (not) die? The role of autophagy in cardiomyocyte homeostasis and cell death. Heart Fail Rev 2009 Feb 25.
  1. Domaniski D, Rosanio S, Schwarz ER. Improved erectile function after cardiac resynchronization therapy in a patient with heart failure – a case report. J Sex Med 2009 J Sex Med. 2009 Oct;6(10):2910-4.
  1. Tehrani F, Phan A, Morrissey R, Chien C, Rafique A, Schwarz ER. The prognostic vlaue of anemia in patients with diastolic heart failure. Texas Heart Institute Journal 2009 Tex Heart Inst J. 2009;36(3):220-5.
  1. Tehrani F, Morrisey R, Phan A, Chien C, Schwarz ER. Statin therapy in patients with diastolic heart failure. Clinical Cardiology 2009.
  1. Kunju SU, Badarudeen S, Schwarz ER. Impact of obesity in patients with congestive heart failure. Rev Cardiovasc Med 2009 Summer;10:142-51.
  1. Simsir SA, Schwarz ER, Czer LS, Hamburg SI. Heart transplantation using bivalirudin as anticoagulant.Interact Cardiovasc Thorac Surg. 2009 Oct 1. [Epub ahead of print]
  1. Schwarz ER, Rosanio S. Religion and the Catholic Church's View on (Heart) Transplantation: A Recent Statement of Pope Benedict XVI and its Practical Impact. J Relig Health 2009 Sep 26. [Epub ahead of print].
  1. Domanski D, Schwarz ERClinical Review: Is the Perioperative Use of {beta}-Blockers Still Recommended? A Critical Review of Recent Controversies. J Cardiovasc Pharmacol Ther 2009;14:258-68. Epub 2009 Sep 4.
  1. Fieno DS, Czer LS, Schwarz ER, Simsir S.Left ventricular assist device placement in a patient with end-stage heart failure and human immunodeficiency virus. Interact Cardiovasc Thorac Surg 2009;9:919-20. Epub 2009 Aug 25.
  1. Unes Kunju S, Naim HJ, Czer L, Simsir, S, Schwarz ER. Acute cellular transplant rejection following laparoscopic adjustable gastric banding in a morbidly obese patient post heart transplantation. Acute cellular transplant rejection following laparoscopic adjustable gastric banding in a morbidly obese patient post heart transplantation. Cardiovasc Med (Hagerstown). 2009 Nov 11. [Epub ahead of print]


  1. Thompson KA, Philip KJ, Simsir S, Schwarz ERThe New Concept of "Interventional Heart Failure Therapy": Part 2--Inotropes, Valvular Disease, Pumps, and Transplantation. J Cardiovasc Pharmacol Ther. 2010 Jul 1. [Epub ahead of print]
  1. Morrissey RP, Philip KJ, Schwarz ERReconciling Q waves and late gadolinium enhancement with no angiographic evidence of coronary disease: cardiac sarcoidosis presenting as decompensated heart failure. Cardiovasc J Afr. 2010 May-Jun;21(3):158-63.
  1. Schwarz ER, Czer LS, Simsir SA, Kass RM, Trento A. Amiodarone-induced QT prolongation in a newly transplanted heart associated with recurrent ventricular fibrillation. Cardiovasc J Afr. 2010 Mar-Apr;21(2):109-12.
  1. Phan A, Ishak WW, Shen BJ, Fuess J, Philip K, Bresee C, Czer L, Schwarz ER. Persistent Sexual Dysfunction Impairs Quality of Life after Cardiac Transplantation. J Sex Med. 2010 May 19. [Epub ahead of print]
  1. Agarwal M, Naghi J, Philip K, Phan A, Willix RD Jr, Schwarz ERGrowth hormone and testosterone in heart failure therapy. Expert Opin Pharmacother. 2010 Aqg;11(11):1835-44.
  1. Falk JA, Philip KJ, Schwarz ER.The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension. Vasc Health Risk Manag. 2010 May 6;6:273-80.
  1. Thompson KA, Philip KJ, Barbagelata A, Schwarz ERReview article: the new concept of interventional heart failure therapy--part 1: electrical therapy, treatment of CAD, fluid removal, and ventricular support. J Cardiovasc Pharmacol Ther. 2010 Jun;15(2):102-11.
  1. Schwarz ER, Philip KJ, Simsir SA, Czer L, Trento A, Finder SG, Cleenewerck LA. Maximal care considerations when treating patients with end-stage heart failure: ethical and procedural quandaries in management of the very sick. J Relig Health. 2010 Feb 27. [Epub ahead of print]
  1. Tehrani F, Morrissey R, Phan A, Chien C, Schwarz ERStatin therapy in patients with diastolic heart failure. Clin Cardiol. 2010 Apr;33(4):E1-5.
  1. Thompson KA, Philip KJ, Simsir S, Schwarz ERThe new concept of ''interventional heart failure therapy'': part 2--inotropes, valvular disease, pumps, and transplantation. J Cardiovasc Pharmacol Ther 2010;15:231-43.
  1. Morrissey RP, Philip KJ, Schwarz ERReconciling Q waves and late gadolinium enhancement with no angiographic evidence of coronary disease: cardiac sarcoidosis presenting as decompensated heart failure. Cardiovasc J Afr 2010;21:158-63.
  1. Baraghoush A, Phan A, Willix RD Jr, Schwarz ERErectile dysfunction as a complication of heart failure. Curr Heart Fail Rep 2010;7:194-201.
  1. Thompson KA, Bharadwaj P, Philip KJ, Schwarz ERHeart failure therapy: beyond the guidelines. J Cardiovasc Med (Hagerstown) 2010;11:919-27.
  1. Schwarz ER, Dashti R. The clinical quandary of left and right ventricular diastolic dysfunction and diastolic heart failure. Cardiovasc J Afr 2010;21:212-20.
  1. Wang H, Goland S, Burton K, Czer LS, Schwarz ER, Trento A. An agonist of liver X receptor slows valvular disease in a hypercholesterolemia mouse model. J Heart Valve Dis 2010;19:653-64.
  1. Schwarz ER, Cleenewerck L, Phan A, Bharadwaj P, Hobbs R. Philosophical Implications of the Systemic and Patient-Oriented Management of Chronic Heart Failure. J Relig Health 2010 Nov 19. [Epub ahead of print]
  1. Naghi JJ, Philip KJ, Dilibero D, Willix R, Schwarz ERTestosterone Therapy: Treatment of Metabolic Disturbances in Heart Failure. J Cardiovasc Pharmacol Ther. 2010 Nov 19. [Epub ahead of print]
  1. Thompson KA, Philip KJ, Schwarz ERClinical Applications of Bivalirudin in the Cardiac Catheterization Laboratory. J Cardiovasc Pharmacol Ther. 2010 Nov 19. [Epub ahead of print]
  1. Shen BJ, Eisenberg SA, Maeda U, Farrell KA, Schwarz ER, Penedo FJ, Bauerlein EJ, Mallon S. Depression and Anxiety Predict Decline in Physical Health Functioning in Patients with Heart Failure. Ann Behav Med. 2010 Dec 23. [Epub ahead of print]
  1. Cleenewerck L, Schwarz ER. The recovery of Eucharistic and holographic ecclesiology as a promising avenue of ecumenical dialogue and broader mutual recognition. J Ecumen Stud 2010;45:561-77.
  1. Daneshvar DA, Czer LS, Phan A, Trento A, Schwarz ERHeart transplantation in the elderly: why cardiac transplantation does not need to be limited to younger patients but can be safely performed in patients above 65 years of age. Ann Transplant. 2010 Dec 22;15(4):110-9.


  1. Morrissey RP, Philip KJ, Schwarz ERCardiac abnormalities in Anderson-Fabry disease and Fabry's cardiomyopathy. Cardiovasc J Afr. 2011 Jan-Feb;22(1):38-44. Review.
  1. Agarwal M, Phan A, Willix R Jr, Barber M, Schwarz ERIs Vitamin D Deficiency Associated With Heart Failure? A Review of Current Evidence. J Cardiovasc Pharmacol Ther. 2011 Feb 8. [Epub ahead of print]
  1. Eisenberg SA, Shen BJ, Schwarz ER, Mallon S. Avoidant coping moderates the association between anxiety and patient-rated physical functioning in heart failure patients. J Behav Med. 2011 Jun 10. [Epub ahead of print]
  1. White AJ, Smith RR, Matsushita S, Chakravarty T, Czer LS, Burton K, Schwarz ER, Davis DR, Wang Q, Reinsmoen NL, Forrester JS, Marbán E, Makkar R. Intrinsic cardiac origin of human cardiosphere-derived cells. Eur Heart J. 2011 Jun 9. [Epub ahead of print]
  1. Zaya M, Phan A, Schwarz ERThe dilemma, causes and approaches to avoid recurrent hospital readmissions for patients with chronic heart failure. Heart Fail Rev. 2011 Jun 5. [Epub ahead of print]
  1. Perkel D, Naghi J, Agarwal M, Morrissey RP, Phan A, Willix RD Jr, Schwarz ERThe Potential Effects of IGF-1 and GH on Patients With Chronic Heart Failure. J Cardiovasc Pharmacol Ther. 2011 Mar 31. [Epub ahead of print]
  1. Dhesi P, Simsir SA, Daneshvar D, Rafique A, Phan A, Schwarz ERLeft ventricular assist device as 'bridge to weight loss' prior to transplantation in obese patients with advanced heart failure. Ann Transplant. 2011 Mar 23;16(1):5-13.
  1. Morrissey RP, Rana JS, Luthringer DJ, Cheng V, Czer LS, Philip K, Kass R, Schwarz ERCase of fulminant giant-cell myocarditis associated with polymyositis, treated with a biventricular assist device and subsequent heart transplantation. Heart Lung. 2011 Jul-Aug;40(4):340-5. Epub 2011 Mar 21.
  1. Aaronson AJ, Morrissey RP, Nguyen CT, Willix R, Schwarz ERUpdate on the safety of testosterone therapy in cardiac disease. Expert Opin Drug Saf. 2011 Mar 22. [Epub ahead of print]
  1. Nguyen CT, Aaronson A, Morrissey RP, Agarwal M, Willix RD, Schwarz ERMyths and truths of growth hormone and testosterone therapy in heart failure. Expert Rev Cardiovasc Ther. 2011 Jun;9(6):711-20.
  1. Thompson KA, Dhesi P, Nguyen D, Czer L, Moriguchi J, Schwarz ER Evaluation of the HeartMate II™ left ventricular assist device in obese heart failure patients: Effects on weight loss. Ann Transplant. 2011 Jun 30;16(2):63-7.


  1. Udeoji DU, Schwarz ERTadalafil as monotherapy and in combination regimens for the treatment of pulmonary arterial hypertension. Ther Adv Respir Dis. 2013 Feb;7(1):39-49. doi: 10.1177/1753465812463627. Epub 2012 Nov 5. Review.
  1. Zaya M, Phan A, Schwarz ERPredictors of re-hospitalization in patients with chronic heart failure. World J Cardiol. 2012 Feb 26;4(2):23-30. doi: 10.4330/wjc.v4.i2.23.
  1. Thompson KA, Morrissey RP, Phan A, Schwarz ERDoes the United States economy affect heart failure readmissions? A single metropolitan center analysis. Clin Cardiol. 2012 Aug;35(8):474-7. doi: 10.1002/clc.21996. Epub 2012 Apr 20.
  1. Schwarz ER, Willix RD Jr. Impact of a physician-supervised exercise-nutrition program with testosterone substitution in partial androgen-deficient middle-aged obese men. J Geriatr Cardiol. 2011 Dec;8(4):201-6.
  1. Udeoji DU, Shah AB, Bharadwaj P, Katsiyiannis P, Schwarz EREvaluation of the prevalence and severity of pain in patients with stable chronic heart failure. World J Cardiol. 2012 Aug 26;4(8):250-5.
  1. Alvarez PA, Schwarz ER, Ramineni R, Myatt P, Barbin C, Boissonnet C, Phan A, Maggioni A, Barbagelata A. Periprocedural adverse events in cell therapy trials in myocardial infarction and cardiomyopathy: a systematic review. Clin Res Cardiol. 2013 Jan;102(1):1-10. doi: 10.1007/s00392-012-0508-3. Epub 2012 Sep 28. Review.
  1. Shah AB, Udeoji DU, Baraghoush A, Bharadwaj P, Yennurajalingam S, Schwarz ERAn evaluation of the prevalence and severity of pain and other symptoms in acute decompensated heart failure. J Palliat Med. 2013 Jan;16(1):87-90. doi: 10.1089/jpm.2012.0248. Epub 2012 Dec 28.


  1. Shah AB, Morrissey RP, Baraghoush A, Bharadwaj P, Phan A, Hamilton M, Kobashigawa J, Schwarz ERFailing the failing heart: a review of palliative care in heart failure. Rev Cardiovasc Med. 2013;14(1):41-8. Review.
  1. Yanagida R, Czer LS, Ruzza A, Schwarz ER, Simsir SA, Jordan SC, Trento A. Use of ventricular assist device as bridge to simultaneous heart and kidney transplantation in patients with cardiac and renal failure. Transplant Proc. 2013 Jul-Aug;45(6):2378-83. doi: 10.1016/j.transproceed.2013.02.115.
  1. Udeoji DU, Philip KJ, Morrissey RP, Phan A, Schwarz ERLeft ventricular noncompaction cardiomyopathy: updated review. Ther Adv Cardiovasc Dis. 2013 Oct;7(5):260-73.


  1. Tadwalkar R, Udeoji DU, Weiner RJ, Avestruz FL, Lachance D, Phan A, Nguyen D, Bharadwaj P, Schwarz ERThe Beneficial Role of Spiritual Counseling in Heart Failure Patients. J Relig Health. 2014 Apr 24
  1. Biswas OS, Gonzalez VR, Schwarz EREffects of an Oral Nitric Oxide Supplement on Functional Capacity and Blood Pressure in Adults With Prehypertension. J Cardiovasc Pharmacol Ther. 2014 Jun 18.
  1. Udeoji DU, Schwarz ERSwitching from nitrate therapy to ranolazine in patients with coronary artery disease receiving phosphodiesterase type-5 inhibitors for erectile dysfunction. Clin Med Insights Case Rep. 2014 Nov 19;7:131-4. doi: 10.4137/CCRep.S16915.


  1. Muhandiramge D, Udeoji DU, Biswas OS, Bharadwaj P, Black LZ, Mulholland KA, Moschella C, Schwarz ERPalliative care issues in heart transplant candidates. Curr Opin Support Palliat Care. 2015 Mar;9(1):5-13.